Ian M.Wright


Tokyo + 81.3.6744.1632

Ian Wright represents public and private companies on cross-border commercial transactions, including M&A, divestitures, joint ventures, and licensing matters. He also advises international companies on establishing and maintaining operations in Japan and Japanese companies on anticorruption risks related to outbound M&A.

Ian's experience covers a wide range of business sectors, including life sciences, technology, energy, and manufacturing. From 2009 until 2011, Ian worked as in-house counsel at a multinational health care company supporting its pharmaceutical subsidiary in Japan.

Ian has practiced law in Japan for more than 10 years. His prior professional experience includes work in the corporate and securities department of an international law firm in the United States. Ian is a graduate of the Inter-University Center for Japanese Language Studies in Yokohama, Japan and works comfortably with clients in both Japanese and English.


  • OMRON Nohgata sells 80 percent stake to AdvantechJones Day advised OMRON Corporation in the sale of an 80 percent interest in OMRON Nohgata to Advantech.
  • TDK acquires InvenSense for $1.3 billionJones Day advised TDK Corporation in its $1.3 billion acquisition of InvenSense, Inc.
  • TonenGeneral Sekiyu combines with JX GroupJones Day advised TonenGeneral Sekiyu K.K. in connection with the business integration with JX Group, which forms the largest oil refiner in Japan.
  • Kowa Pharmaceuticals America announces agreement with CymaBay Therapeutics to license gout compoundJones Day advised Kowa Company, Ltd. and its subsidiary Kowa Pharmaceuticals America, Inc. in a license agreement with CymaBay Therapeutics for exclusive U.S. rights to Arhalofenate, a compound in late stage clinical development for the treatment of gout.
  • Marubeni Corporation sells 50 percent interest in Illinois company engaged in leasing of railroad freight rolling stockJones Day advised Marubeni Corporation on the sale of a 50 percent interest in an Illinois company engaged in the business of leasing railroad freight cars.
  • SDS Biotech acquires Sree RamcidesJones Day advised SDS Biotech K.K., a subsidiary of Idemitsu Kosan Co., Ltd., in connection with the acquisition of 65% of the shares of Sree Ramcides Chemicals Pvt. Ltd., a Chennai-based agrichemicals manufacturer, from ePlanet Capital and certain minority shareholders.
  • Molycorp acquires rare earth processor Neo Material Technologies in CDN$1.3 billion (US$1.26 billion) transactionJones Day advised Molycorp, Inc. in its CDN$1.3 billion (US$1.26 billion) acquisition of Neo Material Technologies Inc.
  • Japanese owner divests U.S. insurance brokerage subsidiary to a global U.S.-based risk management firmJones Day represented Japanese owner in divestiture of U.S. insurance brokerage subsidiary with offices in New York, Chicago, and Los Angeles to a global U.S.-based risk management firm.
  • Molycorp forms joint venture with Mitsubishi and Daido Steel to manufacture rare earth magnetsJones Day advised Molycorp Minerals LLC with its entry into a Japanese joint venture with Mitsubishi Corporation and Daido Steel.
  • Idemitsu Kosan Co. forms Nghi Son Refinery & Petrochemical Limited Liability CompanyJones Day advised Idemitsu Kosan Co., Ltd. in connection with the establishment of the joint venture Nghi Son Refinery & Petrochemical Limited Liability Company for the conduct of the engineering design and construction of the Nghi Son Refinery & Petrochemical Complex.
  • Compagnie de Fives-Lille acquires Sandvik Sorting SystemsJones Day advised Compagnie de Fives-Lille in its acquisition of Sandvik Sorting Systems, a producer of postal, parcel and baggage handling sorting systems, from Sandvik AB.
  • Major Japanese company bids (subsequently terminated) for a U.S. power company out of a Chapter 11 proceedingJones Day advised a major Japanese company in its bid (subsequently terminated) for a U.S. company in the power turbine business out of a Chapter 11 proceeding.
  • Speaking Engagements

    • June 2016
      ジョーンズ・デイ ライフサイエンスセミナー:近時の EUにおけるデータに関する新情勢
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.